Portfolio company
Vivere Oncotherapies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
TILT Biotherapeutics
This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.
OverT Bio
This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Neobe
The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
Verismo Therapeutics
This company develops chimeric antigen receptor therapies for patients with solid tumours and B-cell lymphomas.